Waltham, MA-based PerkinElmer (NYSE:[[ticker:PKI]]), a provider of research technologies and diagnostics, has acquired VisEn Medical for an undisclosed sum, according to the companies. Bedford, MA-based VisEn, which makes in vivo fluorescence imaging products, was co-founded in 2000 by Ralph Weissleder, the director of the Center for Systems Biology at Massachusetts General Hospital, and company CEO Kirkland Poss. Poss was not immediately available for comment this morning. VisEn’s venture backers include Cambridge, MA-based Flagship Ventures and Merck Capital Ventures. Ed Kania, co-founder and managing partner of Flagship, was the chairman of VisEn.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
